Anatomic Pathology Market Size, Share, Growth Analysis, By Product (Instruments, Consumables), By Application (Disease Diagnostics, Medical Research), By End Use, By Region - Industry Forecast 2025-2032
해부 병리학 시장 규모는 2023년에 377억 1,000만 달러로 평가되며, 2024년 404억 6,000만 달러에서 2032년에는 703억 2,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 7.3%로 성장할 전망입니다.
세계의 해부 병리학 시장은 임상적인 의사결정을 강화하고 환자 예후를 개선하기 위해 질병 발병에 대한 임상 바이오마커의 사용이 증가함에 따라 견고한 성장이 예상됩니다. 특히 인도, 중국 등 개발도상국에서는 바이오마커 기반 병리 검사의 보급과 첨단 기술 도입이 활발히 진행되고 있으며, 이러한 수요가 더욱 증가할 것으로 예상됩니다. 디지털 현미경과 염색 시스템을 포함한 병리검사 장비의 눈부신 발전도 시장 확대에 기여하고 있습니다. 특히 OptraSCAN과 같은 기업은 분석 프로세스를 간소화하는 지능형 솔루션으로 혁신을 주도하고 있으며, Royal Philips와 Ibex Medical Analytics와 같은 협업은 AI를 병리학에 통합하여 혁신을 촉진하고 제품 포트폴리오를 확장하는 것을 목표로 하고 있으며, 제품 포트폴리오를 확장하여 예측 기간 중 이 분야의 지속적인 성장을 보장하는 것을 목표로 하고 있습니다.
목차
서론
조사 방법
- 정보 조달
- 2차 데이터와 1차 데이터 방법
- 시장 규모 예측
- 시장의 전제조건과 제한
개요
- 세계 시장 전망
- 공급과 수요의 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 산업 분석
주요 시장 인사이트
- 주요 성공 요인
- 경쟁의 정도
- 주요 투자 기회
- 에코시스템 지도제작
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 사례 연구
- 기술 평가
- 규제 상황
- 파이프라인 분석
- 질병 역학
- 특허 분석
해부 병리학 시장 규모 : 제품과 서비스별
- 시장 개요
- 기기
- 슬라이드 염색 시스템
- 조직 처리 시스템
- Cell 프로세서
- 마이크로톰과 Cryostat
- 임베디드 시스템
- 커버 슬리퍼
- 기타 제품
- 소모품
- 항체
- 1차 항체
- 2차 항체
- 키트와 시약
- 얼룩과 용제
- 정착제
- 기타 키트와 시약
- 프로브
- 기타 소모품
- 서비스
해부 병리학 시장 규모 : 용도별
- 시장 개요
- 질병 진단
- 암
- 유방암
- 소화기암
- 폐암
- 전립선암
- 기타 암
- 기타 질병
- 의학 조사
- 의약품 발견과 개발
- 기타
해부 병리학 시장 규모 : 최종 용도별
- 시장 개요
- 병원
- 임상 검사실
- 진단 검사실
- 기타
해부 병리학 시장 규모
- 북미
- 유럽
- 독일
- 스페인
- 프랑스
- 영국
- 이탈리아
- 기타 유럽 지역
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 상위 5사의 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 시장의 최근 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업의 기업 개요
- 회사 개요
- 제품 포트폴리오 분석
- 부문별 점유율 분석
- 매출의 전년대비 비교(2022-2024)
주요 기업 개요
- F. Hoffman-LA Roche Ltd.
- Danaher Corporation
- PHC Holdings Corporation
- Abcam Plc.
- Hologic, Inc.
- Agilent Technologies
- Becton, Dickinson And Company
- Sakura Finetek Usa Inc.
- Merck Kgaa
- Bio SB
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Cardinal Health
- NeoGenomics Laboratories, Inc.
- BioGenex
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Siemens AG
- Cell Signaling Technology, Inc.
- PerkinElmer Inc.
결론과 권장사항
KSA
Anatomic Pathology Market size was valued at USD 37.71 Billion in 2023 and is poised to grow from USD 40.46 Billion in 2024 to USD 70.32 Billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).
The global anatomic pathology market is poised for robust growth, driven by the increased utilization of clinical biomarkers for disease pathogenesis, which enhances clinical decision-making and improves patient outcomes. The rising prevalence of biomarker-based pathology tests and advanced technology adoption, particularly in developing nations like India and China, further fuels this demand. Significant advancements in pathology equipment, including digital microscopes and staining systems, are also contributing to market expansion. Notably, companies like OptraSCAN are innovating with intelligent solutions to streamline analysis processes. Collaborations, such as that between Royal Philips and Ibex Medical Analytics, aim to integrate AI into pathology, fostering innovation and broadening product portfolios, thus ensuring continued growth in this sector through the forecast period.
Top-down and bottom-up approaches were used to estimate and validate the size of the Anatomic Pathology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Anatomic Pathology Market Segmental Analysis
Global Anatomic Pathology Market is segmented by product, application, end use and region. Based on product, the market is segmented into instruments, consumables and services. Based on application, the market is segmented into disease diagnostics, medical research, drug discovery and development and others. Based on end use, the market is segmented into hospitals, clinical laboratories, diagnostic laboratories and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Anatomic Pathology Market
The anatomic pathology market is poised for significant growth, primarily driven by the rising incidence of various chronic diseases and evolving consumer lifestyles and dietary habits. Our research indicates that the global population aged 65 and older was approximately 727 million in 2020 and is projected to double to 1.5 billion by 2050. This substantial increase in the elderly demographic is anticipated to generate considerable opportunities for the anatomic pathology market in the near future. As a result, the combination of demographic shifts and the growing burden of chronic conditions will be key factors propelling market expansion throughout the forecast period.
Restraints in the Anatomic Pathology Market
One significant restraint impacting the anatomic pathology market is the limited availability of refurbished anatomic pathology equipment globally. This scarcity poses a challenge, particularly for small and medium-sized hospitals and laboratories that prioritize cost-effectiveness in their investments. As these end users often opt for refurbished equipment to meet their budget constraints, the lack of supply in this segment is anticipated to hinder the overall growth of the anatomic pathology market during the projected period. Therefore, addressing the shortage of affordable, refurbished options is crucial for fostering a more robust market environment.
Market Trends of the Anatomic Pathology Market
The anatomic pathology market is experiencing a notable shift towards advanced technological solutions, driven by the increasing adoption of digital microscopes, staining systems, and gross imaging tools. These innovations offer enhanced accuracy and specificity compared to traditional methods, revolutionizing diagnostic processes. As healthcare providers seek to improve patient outcomes through more reliable and efficient pathology solutions, the demand for sophisticated anatomic pathology equipment is surging. This trend underscores a broader movement towards digitalization and automation in healthcare, presenting lucrative growth opportunities for manufacturers and service providers in the anatomic pathology sector over the next few years.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree Of Competition
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index, 2024
- Pestel Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Case Studies
- Technology Assessment
- Regulatory Landscape
- Pipeline Analysis
- Disease Epidemiology
- Patent Analysis
Global Anatomic Pathology Market Size by Product & Services & CAGR (2025-2032)
- Market Overview
- Instruments
- Slide Staining Systems
- Tissue Processing Systems
- Cell Processors
- Microtomes & Cryostat
- Embedding Systems
- Cover Slippers
- Other Products
- Consumables
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Kits And Reagents
- Stains And Solvents
- Fixatives
- Other Kits and Reagents
- Probes
- Other Consumables
- Services
- Histopathology Services
- Cytopathology Services
Global Anatomic Pathology Market Size by Application & CAGR (2025-2032)
- Market Overview
- Disease Diagnostics
- Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Lung Cancer
- Prostate Cancer
- Other Cancers
- Other Diseases
- Medical Research
- Drug Discovery and Development
- Others
Global Anatomic Pathology Market Size by End Use & CAGR (2025-2032)
- Market Overview
- Hospitals
- Clinical Laboratories
- Diagnostic Laboratories
- Others
Global Anatomic Pathology Market Size & CAGR (2025-2032)
- North America (Product & Services, Application, End Use)
- Europe (Product & Services, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product & Services, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product & Services, Application, End Use)
- Brazil
- Rest of Latin America
- Middle East & Africa (Product & Services, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- F. Hoffman-LA Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PHC Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abcam Plc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson And Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sakura Finetek Usa Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck Kgaa
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio SB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quest Diagnostics Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Laboratory Corporation of America Holdings
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeoGenomics Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioGenex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cell Signaling Technology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
